Physician profile
Michael S Nethers
NPI 1841250966
$1,999.74
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $224 · 2021: $220 · 2022: $164 · 2023: $654 · 2024: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.03 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.21 | 2019-2023 | |
| Novo Nordisk INC | $328.17 | 2020-2024 | Wegovy |
| Astellas Pharma US INC | $260.14 | 2019-2024 | Veozah |
| Hologic Sales and Service, LLC | $181.55 | 2019 | |
| Exeltis, USA INC. | $149.09 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $118.57 | 2023 | |
| Avion Pharmaceuticals | $113.83 | 2020-2023 | Balcoltra |
| Allergan, INC. | $83.39 | 2019-2020 | |
| Pfizer INC. | $64.54 | 2023 | |
| Lilly USA, LLC | $37.29 | 2024 | Zepbound, Jardiance |
| Currax Pharmaceuticals LLC | $23.89 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $19.56 | 2023 | Myfembree |
| Duchesnay USA Incorporated | $17.91 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.07 | 2022 | |
| Myovant Sciences INC. | $16.35 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $15.65 | 2019 | |
| Shield Therapeutics INC | $15.04 | 2022 | |
| Medtronic, INC. | $14.05 | 2024 | Ligasure |
| Sage Therapeutics, LLC | $13.90 | 2022 | |
| Therapeuticsmd, INC. | $12.37 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nethers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.